Home
CLSD
CLSD News

Latest Clearside Biomedical Inc. (CLSD) News on December 18, 2024

Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now

Zacks

6 days ago

Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

GlobeNewswire

23 days ago

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy

Zacks

a month ago

All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a month ago

Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...

GuruFocus.com

a month ago

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a month ago

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a month ago

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For

GuruFocus.com

a month ago

Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For

Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

Simply Wall St.

a month ago

Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

Santen, Arctic Vision sign deal for ARVN001 to treat UME

Pharmaceutical Technology

a month ago

Santen, Arctic Vision sign deal for ARVN001 to treat UME

MT Newswires

a month ago

Clearside's Partner Arctic Vision Enters Collaboration With Santen Pharma for Uveitic Macular Edema Treatment

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

GlobeNewswire

a month ago

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

GlobeNewswire

a month ago

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

GlobeNewswire

a month ago

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

GlobeNewswire

2 months ago

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

GlobeNewswire

2 months ago

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

Morning Movers: Arcadium Lithium surges after deal to be acquired

TipRanks

2 months ago

Morning Movers: Arcadium Lithium surges after deal to be acquired

Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

Benzinga

2 months ago

Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study

MT Newswires

2 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Top Premarket Gainers

MT Newswires

2 months ago

Clearside Biomedical Shares Rise After Phase 2B Trial of Potential Eye Degeneration Treatment Shows Positive Data

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

GlobeNewswire

2 months ago

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

GlobeNewswire

4 months ago

Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD

MT Newswires

4 months ago

Chardan Research Initiates Clearside Biomedical at Buy With $6 Price Target

After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)

Zacks

4 months ago

After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Zacks

4 months ago

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

4 months ago

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire

4 months ago

Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

4 months ago

Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

GlobeNewswire

5 months ago

Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China

GlobeNewswire

5 months ago

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China

Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET

GlobeNewswire

5 months ago

Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

GlobeNewswire

5 months ago

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

GlobeNewswire

6 months ago

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

MT Newswires

6 months ago

Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

GlobeNewswire

6 months ago

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Reuters

6 months ago

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

GlobeNewswire

6 months ago

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

ACCESSWIRE

6 months ago

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

ACCESSWIRE

6 months ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

Sage Potash Grants Stock Options

CNW Group

6 months ago

Sage Potash Grants Stock Options

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

GlobeNewswire

6 months ago

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

BW Energy: Mandatory notifications of trade by primary insiders and close associates

GlobeNewswire

6 months ago

BW Energy: Mandatory notifications of trade by primary insiders and close associates

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Newsfile

6 months ago

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago

Simply Wall St.

6 months ago

Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

GlobeNewswire

7 months ago

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

MT Newswires

7 months ago

HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Clearside Biomedical Inc Earnings Call

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Zacks

7 months ago

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

7 months ago

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

GlobeNewswire

7 months ago

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

GlobeNewswire

8 months ago

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

GlobeNewswire

8 months ago

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

9 months ago

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

GlobeNewswire

9 months ago

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

9 months ago

Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Clearside Biomedical Inc Earnings Call

Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...

GuruFocus.com

9 months ago

Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts

TipRanks

9 months ago

These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

GlobeNewswire

10 months ago

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

InvestorPlace

10 months ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Argus Research

10 months ago

Daily – Vickers Top Buyers & Sellers for 02/12/2024

Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock

Simply Wall St.

10 months ago

Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

GlobeNewswire

10 months ago

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Washington Trust Bancorp, Inc. (NASDAQ:WASH) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Washington Trust Bancorp, Inc. (NASDAQ:WASH) Q4 2023 Earnings Call Transcript

18 Best 52-Week Low Stocks To Buy Now

Insider Monkey

a year ago

18 Best 52-Week Low Stocks To Buy Now

Thomson Reuters StreetEvents

a year ago

Q4 2023 SB Financial Group Inc Earnings Call

Canadian Investment Regulatory Organization Trading Halt - ACB.WT.V

CNW Group

a year ago

Canadian Investment Regulatory Organization Trading Halt - ACB.WT.V

SB Financial Group Inc (SBFG) Reports Mixed Results for Q4 and Full Year 2023

GuruFocus.com

a year ago

SB Financial Group Inc (SBFG) Reports Mixed Results for Q4 and Full Year 2023

Dime Community Bancshares Inc (DCOM) Reports Mixed Financial Outcomes Amidst Strategic Growth ...

GuruFocus.com

a year ago

Dime Community Bancshares Inc (DCOM) Reports Mixed Financial Outcomes Amidst Strategic Growth ...

Comcast (CMCSA) Q4 Earnings Beat Estimates, Revenues Rise Y/Y

Zacks

a year ago

Comcast (CMCSA) Q4 Earnings Beat Estimates, Revenues Rise Y/Y

Why Flexsteel (FLXS) Stock Might be a Great Pick

Zacks

a year ago

Why Flexsteel (FLXS) Stock Might be a Great Pick

4 Stocks With a Solid Net Profit Margin Worth Buying

Zacks

a year ago

4 Stocks With a Solid Net Profit Margin Worth Buying

Advanced Emissions Solutions to Rebrand as Arq, Inc.

GlobeNewswire

a year ago

Advanced Emissions Solutions to Rebrand as Arq, Inc.

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors

GlobeNewswire

a year ago

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors

Office Properties Income Trust Announces 2023 Dividend Allocations

Business Wire

a year ago

Office Properties Income Trust Announces 2023 Dividend Allocations

Profound Medical Announces Non-Brokered Private Placement

GlobeNewswire

a year ago

Profound Medical Announces Non-Brokered Private Placement

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Northern Technologies International (NASDAQ:NTIC) Could Be Struggling To Allocate Capital

Simply Wall St.

a year ago

Northern Technologies International (NASDAQ:NTIC) Could Be Struggling To Allocate Capital

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Insider Monkey

a year ago

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Polestar announces Board and Management appointments

Business Wire

a year ago

Polestar announces Board and Management appointments

LION AWARDED $38 MILLION AS PART OF THE EPA'S LATEST ROUND OF CLEAN SCHOOL BUS PROGRAM FUNDING

CNW Group

a year ago

LION AWARDED $38 MILLION AS PART OF THE EPA'S LATEST ROUND OF CLEAN SCHOOL BUS PROGRAM FUNDING

New Strong Sell Stocks for January 10th

Zacks

a year ago

New Strong Sell Stocks for January 10th

Business Wire

a year ago

Regional Management Corp. to Report Fourth Quarter 2023 Results on Wednesday, February 7, 2024

ON24 Named a Leader in 2023-2024 IDC MarketScape for Virtual Events Applications

Business Wire

a year ago

ON24 Named a Leader in 2023-2024 IDC MarketScape for Virtual Events Applications

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

GlobeNewswire

a year ago

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

ACCESSWIRE

a year ago

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%

Simply Wall St.

a year ago

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%

Thomson Reuters StreetEvents

a year ago

Q2 2024 AngioDynamics Inc Earnings Call

Why AngioDynamics Stock Got Destroyed Today

Motley Fool

a year ago

Why AngioDynamics Stock Got Destroyed Today

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

GlobeNewswire

a year ago

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Does Skillsoft Corp. (SKIL) Have the Potential to Rally 180.86% as Wall Street Analysts Expect?

Zacks

a year ago

Does Skillsoft Corp. (SKIL) Have the Potential to Rally 180.86% as Wall Street Analysts Expect?

Business Wire

a year ago

Regional Management Corp. Announces Departure of Chief Operating Officer John Schachtel

Recent Price Trend in Brainsway Ltd. Sponsored ADR (BWAY) is Your Friend, Here's Why

Zacks

a year ago

Recent Price Trend in Brainsway Ltd. Sponsored ADR (BWAY) is Your Friend, Here's Why

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

ACCESSWIRE

a year ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

Share on Social Networks: